Cubist Systematic Strategies LLC Takes Position in LENSAR, Inc. $LNSR

Key Points

• Cubist Systematic Strategies LLC has invested approximately $369,000 in LENSAR, Inc., acquiring 26,136 shares, representing about 0.22% of the company.
• Several other institutional investors have also purchased shares of LENSAR in the first quarter, leading to 40.15% of the stock being owned by them collectively.
• LENSAR reported a loss of ($0.15) earnings per share in its recent quarterly earnings, missing analysts' estimates, while its revenue for the quarter was $11.36 million, below the expected $16.55 million.

Cubist Systematic Strategies LLC purchased a new position in LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 26,136 shares of the company's stock, valued at approximately $369,000. Cubist Systematic Strategies LLC owned about 0.22% of LENSAR at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Groupe la Francaise purchased a new position in LENSAR in the first quarter worth about $1,779,000. OMERS ADMINISTRATION Corp purchased a new position in LENSAR in the first quarter worth about $1,680,000. Huntleigh Advisors Inc. purchased a new position in LENSAR in the first quarter worth about $1,069,000. Draper Asset Management LLC purchased a new position in shares of LENSAR in the first quarter worth approximately $565,000. Finally, Tabor Asset Management LP purchased a new position in shares of LENSAR in the first quarter worth approximately $452,000. 40.15% of the stock is currently owned by hedge funds and other institutional investors.

LENSAR Price Performance

Shares of LNSR traded up $0.32 on Wednesday, reaching $12.67. The company's stock had a trading volume of 80,178 shares, compared to its average volume of 60,763. The stock has a market capitalization of $151.28 million, a P/E ratio of -3.01 and a beta of 0.49. The stock's 50 day simple moving average is $12.70 and its two-hundred day simple moving average is $13.36. LENSAR, Inc. has a 12-month low of $4.03 and a 12-month high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.07). The business had revenue of $11.36 million for the quarter, compared to analysts' expectations of $16.55 million. LENSAR had a negative return on equity of 737.30% and a negative net margin of 84.49%.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.